generic glp-1 agonist Receptor Services for Type 2 Diabetes and Obesity Drug Development Letter: Association Between Incretin Mimetics
Description
doi: 10.7759/cureus.38379
Interested in writing for WiNUK yourself
doi: 10.1038/304368a0 [DOI] [PubMed] [Google Scholar] 21
Vildagliptin: summary of product characteristics
PubMed pubmed.ncbi.nlm.nih.gov [65] What is the pipeline for future medications for obesity
